Council of Institutional Investors Rings the Closing Bell
About This EventThe Council of Institutional Investors staff, board of directors and local member representatives visit the Nasdaq MarketSite in Times Square, to commemorate CII’s 40th anniversary, ...
Nasdaq and BCG Report Reveals How Banks Can Reduce Complexity and Unlock Opportunity
The global financial system has reached unprecedented levels of complexity, but banks now have better tools available to tackle these challenges head-on. A new report released today, January 22, from ...
A Hidden Winner in Manufacturing and Energy Set for a Breakout
Institutional buyers from Geode Capital Management decided to boost their holdings in Xometry stock by 4.3% as of November 2024, bringing their net position to a high of $18.3 million today. They were ...
Gold's Momentum Persists: Leading ETF and 2 Stocks to Watch
The price of gold and the SPDR Gold Shares ETF (NYSEARCA: GLD) delivered exceptional returns in 2024, with GLD surging over 30%, outperforming the benchmark and broader market. This trend has ...
Transports Are Trending Higher: It’s a Golden Time to Buy More
The transportation average has trended higher for the last two years and is set to reach new highs this year. The price action in early 2025 is bullish, confirming the trend with a strong signal, ...
Tech Titans in Chips: 3 Semiconductor Stocks Worth Buying Now
The semiconductor industry is experiencing rapid growth, driven by an increase in demand due to rapid technological advancements. This surge in demand presents a significant opportunity for investors, ...
Stanley Black & Decker Earnings Preview: What to Expect
For the full fiscal 2024, its adjusted EPS is expected to surge by a notable 184.8% year-over-year to $4.13. While in fiscal ...
IPO Revival Likely to Continue into Mid-2025
According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...
There May Still Be Time to Get in on These 3 Trending Biotechs
Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...
Congress Is Gearing Up for a Fight Over Trump’s Tax Cuts
At issue is the Tax Cuts and Jobs Act of 2017, which was a hallmark of Trump’s first term. Abbreviated TCJA, the law made sweeping changes to the U.S. tax code that slashed the average person’s income ...
The New Growth Imperative
Nasdaq’s latest report measures the cost of complexity across the financial system and provides new and fresh perspectives on how institutions can adapt to the exponential growth of complexity while ...
Top ETFs That Beat the Market in 2024 and Could Do It Again
2024 was an incredible year for exchange-traded funds (ETFs) as an investment vehicle, with investors funneling a record-breaking $1.1 trillion in new assets into these funds. With new ETFs launching ...